SCHEMBL28291644

SCHEMBL28291644

CCOc1ccc(-c2ccc(C(C)(C)CN)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.50
TDP1 Q9NUW8 2/20 0.47
TAAR1 Q96RJ0 1/20 0.47
TSHR P16473 1/20 0.47
KIF11 P52732 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 4/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
XDH P47989 1/20 0.41
LMNA P02545 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP10 Q53GL7 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8509041 0.94 NQO1 (0.56) NQO1TDP1TAAR1TSHRKIF11
SCHEMBL10961852 0.82 TAAR1 (0.65) TAAR1KIF11SMN1; SMN2CYP3A4MAPT
SCHEMBL28290197 0.81 NQO1 (0.54) NQO1TDP1TSHRKIF11SMN1; SMN2
SCHEMBL13761773 0.81 NQO1 (0.58) NQO1TDP1TSHRKIF11SMN1; SMN2
SCHEMBL13211694 0.79 NQO1 (0.61) NQO1TDP1TSHRKIF11SMN1; SMN2
SCHEMBL805161 0.79 NQO1 (0.61) NQO1TDP1TSHRMAPTNPC1
SCHEMBL18417193 0.78 NQO1 (0.82) NQO1TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL5833291 0.78 NQO1 (0.82) NQO1TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL9155582 0.78 NQO1 (0.82) NQO1TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL9074434 0.78 NQO1 (0.54) NQO1TDP1TSHRSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-A modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2019-04-02 CN claimed
CN-109563103-A modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2019-04-02 CN disclosed